SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-049491
Filing Date
2018-09-14
Accepted
2018-09-14 16:06:08
Documents
4
Period of Report
2018-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv502681_8k.htm 8-K 22328
2 EXHIBIT 99.1 tv502681_ex99-1.htm EX-99.1 13141
3 GRAPHIC image_002.jpg GRAPHIC 8552
4 GRAPHIC image_001.jpg GRAPHIC 5911
  Complete submission text file 0001144204-18-049491.txt   57049
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 181071186
SIC: 2834 Pharmaceutical Preparations